GNH USA

Europe — EMA

Myditin (Pridinol Mesilate)

GNH USA supplies Myditin (Pridinol mesilate), a muscle relaxant for muscle spasm, spasticity and musculoskeletal pain. Request a quote for global supply.

Pridinol Mesilate

Request sourcing

1
Pack/s

What is Pridinol Mesilate?

Pridinol mesilate, the active ingredient in Myditin, is a muscle relaxant presented as an oral formulation for oral use. It is employed to reduce excessive muscle tone in conditions such as muscle spasm, spasticity and related musculoskeletal discomfort.

GNH USA supplies Myditin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory‑approved batches to meet global demand. Clients benefit from reliable logistics, documentation support and consistent product availability across multiple markets.

What is Pridinol Mesilate used for?

Myditin (pridinol mesilate) is used in the management of skeletal muscle disorders where excessive tone or involuntary contraction occurs.

- Muscle spasm: reduction of painful, involuntary muscle contractions. - Spasticity associated with neurological disorders: alleviation of heightened muscle tone. - Acute musculoskeletal pain: relief of discomfort following strain or injury. - Post‑operative muscle stiffness: facilitation of mobility during recovery.

What are the side effects of Pridinol Mesilate?

Common Side Effects: - Dry mouth - Dizziness - Nausea - Blurred vision - Constipation - Fatigue

Serious or Rare Side Effects: - Severe allergic reaction (anaphylaxis) - Hepatotoxicity (elevated liver enzymes, jaundice) - Cardiac arrhythmia - Seizures - Neutropenia - Acute urinary retention

What precautions apply to Pridinol Mesilate?

Before initiating therapy, consider the following precautions: - Assess renal and hepatic function: adjust use based on organ status. - Avoid in patients with known hypersensitivity to anticholinergic agents. - Use caution in the elderly: increased susceptibility to anticholinergic burden. - Monitor for signs of urinary retention or gastrointestinal obstruction. - Avoid concomitant use with other central anticholinergics unless medically justified. - Store at room temperature: keep in the original pack, protect from moisture and light.

What does Pridinol Mesilate interact with?

Pridinol mesilate may interact with several drug classes:

Major Interactions (Avoid): - Other anticholinergic drugs: risk of excessive anticholinergic effects. - Monoamine oxidase inhibitors (MAOIs): potential hypertensive crisis. - QT‑prolonging agents: increased risk of cardiac arrhythmias.

Moderate Interactions (Monitor Closely): - Alcohol: may enhance sedation and dizziness. - Central nervous system depressants (e.g., benzodiazepines): additive drowsiness. - Beta‑blockers: may mask tachycardia related to anticholinergic activity.

Frequently asked questions

What is Myditin used for?+
Myditin contains pridinol mesilate, a skeletal muscle relaxant indicated for relief of muscle spasm, spasticity and related musculoskeletal discomfort. It is prescribed when reduction of excessive muscle tone is required, such as in acute muscle strain, neurological spasticity, or postoperative stiffness.
How does pridinol mesilate work?+
Pridinol mesilate exerts central anticholinergic activity, blocking muscarinic receptors in the brainstem and spinal cord. This reduces excitatory cholinergic input to skeletal muscles, leading to a decrease in muscle tone and alleviation of involuntary contractions.
What is the usual dose of Myditin?+
The dosage of Myditin is individualized by the prescribing healthcare professional based on the patient’s condition, age, renal and hepatic function, and response to therapy. Patients should follow the prescriber’s instructions and not adjust the dose without medical guidance.
Is Myditin safe during pregnancy or breastfeeding?+
Safety data for pridinol mesilate in pregnancy and lactation are limited. The drug should only be used if the potential benefit justifies the possible risk to the fetus or infant, and the decision must be made by a qualified prescriber after evaluating the clinical situation.
How do I order Myditin from GNH USA?+
To request Myditin, submit an enquiry on the product page at gnh-usa.com, specifying the required quantity. GNH USA works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.
How does Myditin compare with other muscle relaxants?+
Compared with other centrally acting muscle relaxants such as baclofen or tizanidine, pridinol mesilate primarily exerts anticholinergic effects rather than GABA‑ergic or α‑2‑adrenergic mechanisms. This difference may influence the side‑effect profile, with less sedation but a higher likelihood of anticholinergic symptoms, making selection dependent on patient tolerance and comorbidities.
How should Myditin be stored?+
Myditin should be stored at room temperature, below 25 °C, in its original packaging. Keep the product away from moisture, direct sunlight and sources of heat. Ensure the container is tightly closed to maintain stability throughout its shelf life.
How is Myditin administered?+
Myditin is taken orally, usually with a glass of water. The tablet (or other oral dosage form) should be swallowed whole and not chewed or crushed unless specifically instructed by a healthcare professional. Administration timing (e.g., with meals) follows the prescriber’s guidance.
What are the most serious risks associated with Myditin?+
The most serious adverse reactions include severe allergic responses such as anaphylaxis, hepatotoxicity, cardiac arrhythmias, and rare cases of seizures or neutropenia. Patients experiencing rash, difficulty breathing, jaundice, irregular heartbeat, or unexplained fever should seek immediate medical attention.
Who should not use Myditin?+
Myditin is contraindicated in individuals with known hypersensitivity to pridinol mesilate or other anticholinergic agents. Caution is advised for patients with uncontrolled glaucoma, severe urinary retention, gastrointestinal obstruction, or significant hepatic impairment. The drug should also be avoided in anyone for whom a safer alternative is available, as determined by the prescriber.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.
Send a sourcing enquiry for this product →

Product details

Drug
Pridinol Mesilate
Route
Oral Use
Manufacturer
Sun-Farm Sp. Z.O.O.
Origin
EU

Related products

Myditin

Myditin

Pridinol Mesilate

Trommsdorff Gmbh & Co. Kg
EU
Myditin

Myditin

Pridinol Mesilate

Mibe Pharma Italia S.R.L.
EU
Myditin

Myditin

Pridinol Mesilate

Mibe Pharma España S.L.U.
EU
Myopridin

Myopridin

Pridinol Mesilate

Strathmann Gmbh & Co. Kg
EU